JOHANNESBURG, Jan 7 (Reuters) – South Africa’s health ministry said in a statement on Thursday that COVID-19 vaccine negotiations with Johnson & Johnson were at an advanced stage and that “developments will be announced soon”.
J&J told Reuters it was committed to continuing engagement with the South African government.
South Africa has recorded the most coronavirus infections on the continent, at roughly 1.15 million. It is yet to start vaccinating or receive its first doses, alarming some scientists and health workers.
(Reporting by Alexander Winning and Promit Mukherjee Editing by Joe Bavier)
- South Africa’s Aspen could produce J&J COVID shots by end-March [https://www.sharenet.co.za/views/views-article.php?views-article=558401]
- Treasury on board with COVID-19 vaccine costs [https://www.enca.com/news/treasury-board-covid-19-vaccine-costs]
- Coronavirus live news: US records highest daily case increase, Brisbane under lockdown as single case reported in Australia [https://www.theguardian.com/world/live/2021/jan/09/us-records-highest-daily-increase-in-cases-brisbane-under-lockdown-as-single-case-reported-in-australia]
- Covid priority list: When will I get the Covid vaccine? [https://www.bbc.co.uk/news/av/health-55153322]
- Nigeria to receive 100,000 doses of COVID-19 vaccine in two weeks [https://www.newsheadlines.com.ng/guardian-news/2021/01/09/nigeria-to-receive-100000-doses-of-covid-19-vaccine-in-two-weeks/]